Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28575324 | 1.00 | GPR84 (0.41) | GPR84FFAR4FFAR1NFKB1ALDH1A1 | |
| SCHEMBL15247077 | 0.97 | GPR84 (0.40) | GPR84FFAR4FFAR1NFKB1ALDH1A1 | |
| SCHEMBL4378460 | 0.94 | GPR84 (0.44) | GPR84FFAR4FFAR1NFKB1ALDH1A1 | |
| SCHEMBL14533072 | 0.94 | GPR84 (0.44) | GPR84FFAR4FFAR1NFKB1ALDH1A1 | |
| SCHEMBL14533070 | 0.94 | GPR84 (0.44) | GPR84FFAR4FFAR1NFKB1ALDH1A1 | |
| SCHEMBL11742369 | 0.93 | ALDH1A1 (0.39) | GPR84FFAR4FFAR1NFKB1ALDH1A1 | |
| SCHEMBL3687762 | 0.92 | GPR84 (0.50) | GPR84FFAR4FFAR1NFKB1PSMD14 | |
| SCHEMBL30787445 | 0.90 | GPR84 (0.54) | GPR84FFAR4FFAR1NFKB1PSMD14 | |
| SCHEMBL30787144 | 0.90 | GPR84 (0.54) | GPR84FFAR4FFAR1NFKB1PSMD14 | |
| SCHEMBL30787281 | 0.90 | GPR84 (0.54) | GPR84FFAR4FFAR1NFKB1PSMD14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6899753-B2 | Highly bleed-alleviating ink composition | BENQ CORPORATION (TW) | 2005-05-31 | — | — | US | claimed |
| US-20030037700-A1 | Highly bleed-alleviating ink composition | MIND FUSION, LLC | 2003-02-27 | — | — | US | claimed |
| CN-112119137-A | Multilayer pressure sensitive adhesive assembly | 3M创新有限公司 | 2020-12-22 | — | — | CN | disclosed |
| EP-2700636-B1 | PROCESS FOR PREPARING EPISULFIDE COMPOUNDS | ASAHI CHEMICAL IND (JP) | 2017-08-02 | — | — | EP | disclosed |
| CN-106831862-A | Axial chirality monophosphorus ligand of one class chirality bridging and preparation method thereof | 中山大学 | 2017-06-13 | — | — | CN | disclosed |
| US-9359324-B2 | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-06-07 | — | — | US | disclosed |
| CN-103476764-B | Process for producing episulfide compound | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2016-05-25 | — | — | CN | disclosed |
| US-20150197501-A1 | Process for Preparing Episulfide Compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-07-16 | — | — | US | disclosed |
| US-9051293-B2 | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-06-09 | — | — | US | disclosed |
| CN-104610222-A | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORP | 2015-05-13 | — | — | CN | disclosed |
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-04-17 | — | — | US | disclosed |
| EP-2700636-A1 | PROCESS FOR PREPARING EPISULFIDE COMPOUNDS | Asahi Kasei Chemicals Corporation (JP) | 2014-02-26 | — | — | EP | disclosed |
| CN-101519552-B | Method for preparing inkjet water-soluble ink containing noble metal nano particles | CHINESE ACAD INST CHEMISTRY | 2011-08-24 | — | — | CN | disclosed |
| CN-101519552-A | Method for preparing inkjet water-soluble ink containing noble metal nano particles | CHINESE ACAD INST CHEMISTRY | 2009-09-02 | — | — | CN | disclosed |
| US-6899753-B2 | Highly bleed-alleviating ink composition | BENQ CORPORATION (TW) | 2005-05-31 | — | — | US | disclosed |
| CN-1401710-A | Ink composition with high ink bleeding prevention | BENQ CORP (CN) | 2003-03-12 | — | — | CN | disclosed |
| US-20030037700-A1 | Highly bleed-alleviating ink composition | MIND FUSION, LLC | 2003-02-27 | — | — | US | disclosed |
| US-6376691-B1 | Metal organic precursors for transparent metal oxide thin films and method of making same | SYMETRIX CORPORATION | 2002-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150197501-A1 | Process for Preparing Episulfide Compounds | TST, EPHX2, STS | GPR84 3934/4885FFAR4 4324/4885FFAR1 4701/4885 |
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | TST, EPHX2, STS | GPR84 3934/4885FFAR4 4324/4885FFAR1 4701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.